Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.

Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.

[This corrects the article DOI: 10.1371/journal.pone.0162407.].

Bibliographic Details
Main Authors:	Francesca Vitali, Laurie D Cohen, Andrea Demartini, Angela Amato, Vincenzo Eterno, Alberto Zambelli, Riccardo Bellazzi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5226782?pdf=render

Similar Items

A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
by: Francesca Vitali, et al.
Published: (2016-01-01)

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
by: Peter Larsson, et al.
Published: (2024-01-01)

A Bayesian data fusion based approach for learning genome-wide transcriptional regulatory networks
by: Elisabetta Sauta, et al.
Published: (2020-05-01)

Trastuzumab Induces Apoptosis and Cell Cycle Arrest in Triple-Negative Breast Cancer, Suggesting Repurposing Potential
by: Shaimaa Abdel-Ghany, et al.
Published: (2024-11-01)

Correction: Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Informatics on Drug Repurposing for Breast Cancer
by: Zhou H, et al.
Published: (2023-06-01)

LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer
by: Ying Liu, et al.
Published: (2024-04-01)

Bioinformatic analysis of drug targets for triple-negative breast cancer
by: Xiao-Wei Li, et al.
Published: (2023-02-01)

Approach to the Triple Negative Breast Cancer in New Drugs Area
by: Mehrzad Mirzania
Published: (2016-04-01)

Screening of GPCR drugs for repurposing in breast cancer
by: Noor Mazin Abdulkareem, et al.
Published: (2022-12-01)

Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
by: Francesca Matilde Schipilliti, et al.
Published: (2024-04-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
by: Alexis Woodward, et al.
Published: (2024-04-01)

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
by: Domiziana Masci, et al.
Published: (2023-11-01)

Research progress in drug repurposing in the treatment of breast cancer
by: TAN Chen, et al.
Published: (2024-11-01)

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer
by: Hye-Jung Nam, et al.
Published: (2022-12-01)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
by: Gennifer Goode, et al.
Published: (2017-01-01)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
by: Kirsten G. M. Aspros, et al.
Published: (2022-02-01)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
by: Samina Gul, et al.
Published: (2023-11-01)

The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
by: Iason Psilopatis, et al.
Published: (2023-03-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
by: Guoyu Wu, et al.
Published: (2022-04-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021-11-01)

Theranostics for Triple-Negative Breast Cancer
by: Hyeryeon Choi, et al.
Published: (2023-01-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Drug repurposing for breast cancer treatment using bioinformatics approach
by: Habib MotieGhader
Published: (2024-08-01)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
by: Justin Bauzon, et al.
Published: (2023-08-01)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
by: Swanner J, et al.
Published: (2015-06-01)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
by: Ji-Yeon Kim, et al.
Published: (2023-07-01)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
by: Homero Gonçalves, et al.
Published: (2018-07-01)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
by: Giuliana Moffa, et al.
Published: (2020-12-01)

Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
by: Yuqin Lin, et al.
Published: (2023-12-01)

Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
by: Farhia Kabeer, et al.
Published: (2024-07-01)

SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
by: Wenwen Geng, et al.
Published: (2023-12-01)

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
by: Weiwei Zeng, et al.
Published: (2023-11-01)

Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment
by: Aman Chandra Kaushik, et al.
Published: (2023-08-01)

Adenosine Overcomes Triple-Negative Breast Cancer Resistance to Platinum-Derived Chemotherapeutic Drugs
by: Ana Cerquido, et al.
Published: (2022-11-01)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422, et al.
Published: (2017)